Steven Edmundowicz
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiopancreatography, Endoscopic Retrograde | 39 | 2025 | 211 | 4.070 |
Why?
| | Endoscopy, Gastrointestinal | 29 | 2023 | 227 | 3.710 |
Why?
| | Endosonography | 30 | 2024 | 156 | 2.120 |
Why?
| | Bariatric Surgery | 12 | 2019 | 214 | 1.860 |
Why?
| | Esophageal Neoplasms | 13 | 2022 | 324 | 1.760 |
Why?
| | Endoscopy, Digestive System | 16 | 2021 | 136 | 1.760 |
Why?
| | Pancreatic Neoplasms | 20 | 2023 | 931 | 1.660 |
Why?
| | Endoscopy | 13 | 2020 | 316 | 1.490 |
Why?
| | Adenoma | 12 | 2023 | 230 | 1.480 |
Why?
| | Pancreatitis | 14 | 2025 | 132 | 1.410 |
Why?
| | Weight Loss | 11 | 2019 | 775 | 1.380 |
Why?
| | Gastric Balloon | 6 | 2018 | 17 | 1.370 |
Why?
| | Obesity | 17 | 2019 | 2975 | 1.330 |
Why?
| | Stents | 20 | 2025 | 528 | 1.300 |
Why?
| | Gastroplasty | 5 | 2019 | 30 | 1.290 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2019 | 132 | 1.150 |
Why?
| | Adenocarcinoma | 13 | 2023 | 936 | 1.140 |
Why?
| | Barrett Esophagus | 10 | 2022 | 149 | 1.100 |
Why?
| | Pancreatic Ducts | 11 | 2024 | 85 | 1.040 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 9 | 2019 | 56 | 1.040 |
Why?
| | Colonic Neoplasms | 6 | 2015 | 256 | 1.030 |
Why?
| | Stomach Neoplasms | 5 | 2020 | 124 | 1.020 |
Why?
| | Drainage | 12 | 2024 | 168 | 1.010 |
Why?
| | Gastroenterology | 10 | 2019 | 181 | 0.950 |
Why?
| | Colonic Polyps | 7 | 2015 | 88 | 0.930 |
Why?
| | Colonoscopy | 12 | 2023 | 247 | 0.930 |
Why?
| | Gastroesophageal Reflux | 11 | 2020 | 234 | 0.880 |
Why?
| | Bile Duct Neoplasms | 4 | 2020 | 123 | 0.800 |
Why?
| | Cholestasis | 3 | 2020 | 232 | 0.730 |
Why?
| | Gastrointestinal Diseases | 4 | 2022 | 209 | 0.720 |
Why?
| | Duodenoscopes | 2 | 2020 | 7 | 0.690 |
Why?
| | Duodenum | 4 | 2019 | 77 | 0.690 |
Why?
| | Pancreatitis, Chronic | 5 | 2024 | 58 | 0.680 |
Why?
| | Esophagus | 8 | 2019 | 255 | 0.660 |
Why?
| | Pancreatic Pseudocyst | 5 | 2024 | 17 | 0.650 |
Why?
| | Humans | 161 | 2025 | 136783 | 0.650 |
Why?
| | Middle Aged | 93 | 2025 | 33200 | 0.640 |
Why?
| | Obesity, Morbid | 7 | 2019 | 258 | 0.640 |
Why?
| | Pancreatic Diseases | 6 | 2023 | 72 | 0.640 |
Why?
| | Biliary Tract Neoplasms | 1 | 2019 | 30 | 0.630 |
Why?
| | Biopsy, Fine-Needle | 8 | 2017 | 68 | 0.630 |
Why?
| | Indomethacin | 4 | 2025 | 81 | 0.620 |
Why?
| | Catheterization | 9 | 2024 | 179 | 0.610 |
Why?
| | Clinical Competence | 11 | 2020 | 1093 | 0.600 |
Why?
| | Aged | 72 | 2025 | 23729 | 0.590 |
Why?
| | Cross Infection | 1 | 2020 | 238 | 0.560 |
Why?
| | Learning Curve | 6 | 2019 | 72 | 0.550 |
Why?
| | Endoscopic Mucosal Resection | 5 | 2022 | 24 | 0.550 |
Why?
| | Radiation Exposure | 1 | 2017 | 49 | 0.550 |
Why?
| | Gastrostomy | 5 | 2019 | 112 | 0.540 |
Why?
| | Intestine, Small | 2 | 2020 | 154 | 0.530 |
Why?
| | Prospective Studies | 36 | 2024 | 7583 | 0.520 |
Why?
| | Colonic Diseases | 3 | 2013 | 33 | 0.520 |
Why?
| | Radiation Injuries | 1 | 2017 | 145 | 0.510 |
Why?
| | Jejunum | 2 | 2015 | 31 | 0.510 |
Why?
| | Treatment Outcome | 36 | 2025 | 10764 | 0.500 |
Why?
| | Smell | 1 | 2016 | 117 | 0.490 |
Why?
| | Self Expandable Metallic Stents | 3 | 2022 | 16 | 0.480 |
Why?
| | Male | 94 | 2025 | 67361 | 0.480 |
Why?
| | Pathology, Clinical | 1 | 2015 | 36 | 0.470 |
Why?
| | Cholelithiasis | 8 | 2010 | 37 | 0.470 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2013 | 77 | 0.470 |
Why?
| | Pancreas | 7 | 2021 | 328 | 0.460 |
Why?
| | Lithotripsy | 6 | 2024 | 48 | 0.460 |
Why?
| | Female | 96 | 2025 | 72840 | 0.460 |
Why?
| | Laparoscopy | 6 | 2020 | 464 | 0.460 |
Why?
| | Suction | 2 | 2017 | 34 | 0.450 |
Why?
| | Catheter Ablation | 5 | 2022 | 349 | 0.430 |
Why?
| | Postoperative Hemorrhage | 3 | 2017 | 87 | 0.430 |
Why?
| | Gallstones | 6 | 1996 | 31 | 0.420 |
Why?
| | Esophagoscopy | 8 | 2022 | 209 | 0.420 |
Why?
| | Postoperative Complications | 11 | 2024 | 2624 | 0.410 |
Why?
| | Adult | 60 | 2025 | 37616 | 0.390 |
Why?
| | Propofol | 4 | 2023 | 73 | 0.390 |
Why?
| | Sensitivity and Specificity | 11 | 2019 | 1942 | 0.380 |
Why?
| | Body Weight | 1 | 2016 | 981 | 0.380 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 4 | 2025 | 350 | 0.370 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2512 | 0.370 |
Why?
| | Biopsy | 5 | 2019 | 1126 | 0.360 |
Why?
| | Gastroscopy | 4 | 2014 | 19 | 0.360 |
Why?
| | Precancerous Conditions | 4 | 2017 | 169 | 0.360 |
Why?
| | Colorectal Neoplasms | 5 | 2022 | 792 | 0.360 |
Why?
| | Aged, 80 and over | 23 | 2025 | 7569 | 0.350 |
Why?
| | Quality Indicators, Health Care | 5 | 2018 | 308 | 0.350 |
Why?
| | Bile Ducts | 5 | 2014 | 71 | 0.340 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 22 | 0.330 |
Why?
| | Cytodiagnosis | 2 | 2020 | 33 | 0.330 |
Why?
| | Ampulla of Vater | 3 | 2023 | 42 | 0.330 |
Why?
| | Pancreatic Cyst | 3 | 2018 | 60 | 0.330 |
Why?
| | Pancreatitis, Acute Necrotizing | 3 | 2023 | 13 | 0.320 |
Why?
| | Insufflation | 1 | 2009 | 12 | 0.320 |
Why?
| | Constriction, Pathologic | 6 | 2022 | 241 | 0.310 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2020 | 317 | 0.300 |
Why?
| | Common Bile Duct Neoplasms | 2 | 2023 | 30 | 0.300 |
Why?
| | Esophagogastric Junction | 3 | 2019 | 51 | 0.300 |
Why?
| | Cholecystectomy, Laparoscopic | 6 | 2008 | 52 | 0.290 |
Why?
| | Retrospective Studies | 35 | 2025 | 15564 | 0.290 |
Why?
| | Calculi | 3 | 2019 | 16 | 0.280 |
Why?
| | Decompression, Surgical | 2 | 2023 | 97 | 0.270 |
Why?
| | Carbon Dioxide | 1 | 2009 | 267 | 0.270 |
Why?
| | Gastrointestinal Stromal Tumors | 3 | 2015 | 38 | 0.260 |
Why?
| | Sphincterotomy, Endoscopic | 6 | 2019 | 28 | 0.260 |
Why?
| | Quality of Life | 11 | 2024 | 2868 | 0.260 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 154 | 0.260 |
Why?
| | Pain, Postoperative | 1 | 2009 | 267 | 0.260 |
Why?
| | Pancreatectomy | 2 | 2021 | 252 | 0.250 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2006 | 14 | 0.250 |
Why?
| | Thoracoscopy | 1 | 2006 | 56 | 0.250 |
Why?
| | Body Mass Index | 7 | 2019 | 2364 | 0.250 |
Why?
| | Follow-Up Studies | 16 | 2015 | 5115 | 0.240 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2023 | 1055 | 0.240 |
Why?
| | Neuroendocrine Tumors | 2 | 2018 | 115 | 0.230 |
Why?
| | Mental Recall | 1 | 2006 | 201 | 0.230 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 419 | 0.230 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2015 | 14 | 0.220 |
Why?
| | Polyvinyls | 1 | 2004 | 20 | 0.220 |
Why?
| | Societies, Medical | 3 | 2018 | 820 | 0.220 |
Why?
| | Magnets | 2 | 2015 | 19 | 0.220 |
Why?
| | Plastics | 3 | 2022 | 48 | 0.220 |
Why?
| | Gastric Bypass | 2 | 2017 | 118 | 0.210 |
Why?
| | Periodicals as Topic | 1 | 2006 | 210 | 0.210 |
Why?
| | Ablation Techniques | 3 | 2017 | 36 | 0.200 |
Why?
| | Common Bile Duct | 3 | 2009 | 17 | 0.200 |
Why?
| | Internet | 2 | 2009 | 648 | 0.200 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 193 | 0.190 |
Why?
| | Patient Satisfaction | 1 | 2006 | 650 | 0.190 |
Why?
| | Fluoroscopy | 3 | 2019 | 157 | 0.190 |
Why?
| | Prostheses and Implants | 3 | 2013 | 143 | 0.190 |
Why?
| | Pneumonia, Aspiration | 2 | 2019 | 18 | 0.190 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 285 | 0.180 |
Why?
| | Deglutition Disorders | 3 | 2019 | 143 | 0.180 |
Why?
| | Risk Factors | 14 | 2025 | 10331 | 0.180 |
Why?
| | Carcinoembryonic Antigen | 3 | 2018 | 39 | 0.170 |
Why?
| | Intestinal Perforation | 2 | 2018 | 46 | 0.170 |
Why?
| | Anesthesia | 1 | 2023 | 191 | 0.170 |
Why?
| | Prosthesis Design | 3 | 2019 | 324 | 0.170 |
Why?
| | Varicose Veins | 1 | 2020 | 17 | 0.170 |
Why?
| | Double-Blind Method | 7 | 2018 | 1981 | 0.170 |
Why?
| | Logistic Models | 7 | 2024 | 2060 | 0.170 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 40 | 0.170 |
Why?
| | Biliary Tract Diseases | 4 | 2014 | 39 | 0.160 |
Why?
| | Neoplasm Staging | 5 | 2017 | 1373 | 0.160 |
Why?
| | Deep Sedation | 2 | 2010 | 14 | 0.160 |
Why?
| | Cell-Free System | 1 | 2019 | 53 | 0.160 |
Why?
| | Equipment Design | 6 | 2020 | 522 | 0.160 |
Why?
| | Abdominal Pain | 3 | 2019 | 145 | 0.160 |
Why?
| | Fiducial Markers | 1 | 2019 | 9 | 0.160 |
Why?
| | Urinary Calculi | 1 | 2019 | 11 | 0.160 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 36 | 0.160 |
Why?
| | Watchful Waiting | 3 | 2019 | 80 | 0.150 |
Why?
| | Needles | 1 | 2019 | 59 | 0.150 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1568 | 0.150 |
Why?
| | Academic Medical Centers | 3 | 2023 | 497 | 0.150 |
Why?
| | Infection Control | 1 | 2020 | 158 | 0.150 |
Why?
| | Esophageal Stenosis | 1 | 2019 | 54 | 0.150 |
Why?
| | Metals | 4 | 2023 | 137 | 0.150 |
Why?
| | Administration, Rectal | 3 | 2024 | 11 | 0.140 |
Why?
| | Abdomen | 2 | 2016 | 125 | 0.140 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 21 | 0.140 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3272 | 0.140 |
Why?
| | Obesity Management | 1 | 2017 | 8 | 0.140 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 91 | 0.140 |
Why?
| | Aneurysm, False | 1 | 2018 | 48 | 0.140 |
Why?
| | Cystadenocarcinoma, Mucinous | 2 | 2015 | 13 | 0.140 |
Why?
| | Cystadenoma, Mucinous | 2 | 2015 | 13 | 0.140 |
Why?
| | Simulation Training | 1 | 2019 | 99 | 0.140 |
Why?
| | Suture Techniques | 3 | 2017 | 122 | 0.140 |
Why?
| | Conscious Sedation | 2 | 2023 | 91 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2023 | 784 | 0.140 |
Why?
| | Calcinosis | 1 | 2019 | 235 | 0.140 |
Why?
| | Education, Medical, Graduate | 2 | 2019 | 481 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 2 | 2016 | 163 | 0.130 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 109 | 0.130 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2017 | 99 | 0.130 |
Why?
| | Diet Therapy | 1 | 2016 | 34 | 0.130 |
Why?
| | Metaplasia | 4 | 2022 | 60 | 0.130 |
Why?
| | Immunoassay | 1 | 2017 | 113 | 0.130 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 1059 | 0.130 |
Why?
| | Respiratory Insufficiency | 2 | 2010 | 316 | 0.130 |
Why?
| | Stomach | 1 | 2016 | 110 | 0.120 |
Why?
| | Population Surveillance | 2 | 2017 | 470 | 0.120 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 27 | 0.120 |
Why?
| | Young Adult | 11 | 2025 | 13126 | 0.120 |
Why?
| | Bariatric Medicine | 1 | 2015 | 2 | 0.120 |
Why?
| | Single-Blind Method | 5 | 2019 | 286 | 0.120 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 77 | 0.120 |
Why?
| | Referral and Consultation | 3 | 2019 | 777 | 0.120 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 620 | 0.120 |
Why?
| | Colon, Ascending | 1 | 2015 | 3 | 0.120 |
Why?
| | Documentation | 1 | 2017 | 189 | 0.120 |
Why?
| | Dogs | 1 | 2016 | 409 | 0.120 |
Why?
| | Dissection | 1 | 2015 | 52 | 0.120 |
Why?
| | Life Style | 2 | 2018 | 484 | 0.120 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 306 | 0.120 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 57 | 0.120 |
Why?
| | Pilot Projects | 2 | 2013 | 1697 | 0.120 |
Why?
| | Cholecystectomy | 4 | 2009 | 60 | 0.120 |
Why?
| | Time Factors | 9 | 2025 | 6792 | 0.120 |
Why?
| | Hospitalization | 1 | 2025 | 2195 | 0.110 |
Why?
| | Peristalsis | 2 | 1991 | 30 | 0.110 |
Why?
| | Proton Pump Inhibitors | 3 | 2020 | 108 | 0.110 |
Why?
| | Aptitude | 1 | 2014 | 39 | 0.110 |
Why?
| | Colorectal Surgery | 1 | 2014 | 24 | 0.110 |
Why?
| | Leiomyoma | 1 | 2015 | 77 | 0.110 |
Why?
| | Multivariate Analysis | 4 | 2021 | 1513 | 0.110 |
Why?
| | Ulcer | 1 | 2014 | 32 | 0.110 |
Why?
| | Colectomy | 1 | 2014 | 100 | 0.110 |
Why?
| | Incidence | 6 | 2025 | 2788 | 0.110 |
Why?
| | Biomarkers, Tumor | 3 | 2017 | 1274 | 0.100 |
Why?
| | Liver Cirrhosis | 2 | 2020 | 316 | 0.100 |
Why?
| | Predictive Value of Tests | 6 | 2016 | 2030 | 0.100 |
Why?
| | Patient Safety | 1 | 2016 | 304 | 0.100 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2013 | 27 | 0.100 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 24 | 0.100 |
Why?
| | Hemorrhage | 1 | 2018 | 723 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 39 | 0.100 |
Why?
| | Ultrasonography, Interventional | 2 | 2015 | 142 | 0.100 |
Why?
| | Community Health Services | 1 | 2014 | 228 | 0.100 |
Why?
| | Bile Duct Diseases | 1 | 2012 | 14 | 0.100 |
Why?
| | Recurrence | 4 | 2020 | 1058 | 0.100 |
Why?
| | Health Care Costs | 1 | 2015 | 385 | 0.100 |
Why?
| | Contrast Media | 1 | 1995 | 462 | 0.100 |
Why?
| | Cholecystitis | 1 | 1992 | 24 | 0.100 |
Why?
| | Exercise Therapy | 1 | 2016 | 434 | 0.100 |
Why?
| | Risk Assessment | 8 | 2016 | 3429 | 0.100 |
Why?
| | Lymph Nodes | 2 | 2012 | 492 | 0.090 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1991 | 4 | 0.090 |
Why?
| | Diverticulum | 1 | 1991 | 12 | 0.090 |
Why?
| | Duodenal Diseases | 1 | 1991 | 8 | 0.090 |
Why?
| | Digestive System Diseases | 1 | 2011 | 26 | 0.090 |
Why?
| | Diagnosis, Differential | 6 | 2015 | 1483 | 0.090 |
Why?
| | Esophageal Diseases | 1 | 1991 | 28 | 0.090 |
Why?
| | Sensation | 1 | 1991 | 53 | 0.090 |
Why?
| | Chest Pain | 1 | 1991 | 91 | 0.090 |
Why?
| | Patient Compliance | 1 | 2015 | 576 | 0.090 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2831 | 0.090 |
Why?
| | Deglutition | 1 | 1991 | 72 | 0.090 |
Why?
| | Hypotension | 1 | 2011 | 122 | 0.090 |
Why?
| | Hepatic Duct, Common | 1 | 2010 | 6 | 0.080 |
Why?
| | Colonoscopes | 1 | 2009 | 5 | 0.080 |
Why?
| | Proteomics | 1 | 2017 | 1108 | 0.080 |
Why?
| | Image Enhancement | 1 | 2011 | 190 | 0.080 |
Why?
| | United States | 10 | 2018 | 14660 | 0.080 |
Why?
| | Muscle, Smooth | 1 | 1991 | 155 | 0.080 |
Why?
| | Bile | 1 | 2009 | 34 | 0.080 |
Why?
| | Cholecystostomy | 1 | 1989 | 4 | 0.080 |
Why?
| | Length of Stay | 5 | 2025 | 1208 | 0.080 |
Why?
| | Disease Progression | 5 | 2017 | 2750 | 0.080 |
Why?
| | Odds Ratio | 4 | 2016 | 1063 | 0.080 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 76 | 0.080 |
Why?
| | Sleep Apnea Syndromes | 1 | 2010 | 89 | 0.080 |
Why?
| | Abdominal Neoplasms | 1 | 2009 | 39 | 0.080 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 51 | 0.080 |
Why?
| | Equipment Safety | 2 | 2009 | 37 | 0.080 |
Why?
| | Tumor Burden | 3 | 2015 | 309 | 0.070 |
Why?
| | Anesthetics | 1 | 2009 | 81 | 0.070 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 50 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2009 | 164 | 0.070 |
Why?
| | Cholangiography | 1 | 2008 | 16 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 3953 | 0.070 |
Why?
| | Adolescent | 8 | 2025 | 21463 | 0.070 |
Why?
| | Choledocholithiasis | 1 | 2008 | 16 | 0.070 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 322 | 0.070 |
Why?
| | Video Recording | 3 | 2014 | 181 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2013 | 648 | 0.070 |
Why?
| | Ultrasonography | 4 | 1996 | 751 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 400 | 0.070 |
Why?
| | Positron-Emission Tomography | 1 | 2008 | 295 | 0.070 |
Why?
| | Biopsy, Needle | 2 | 2004 | 189 | 0.070 |
Why?
| | Acute Disease | 4 | 2008 | 1006 | 0.070 |
Why?
| | Registries | 1 | 2015 | 2015 | 0.070 |
Why?
| | Hyperplasia | 2 | 2019 | 175 | 0.060 |
Why?
| | Pleural Diseases | 1 | 2006 | 23 | 0.060 |
Why?
| | Pancreatic Fistula | 1 | 2006 | 30 | 0.060 |
Why?
| | Research Design | 2 | 2016 | 1107 | 0.060 |
Why?
| | Prognosis | 5 | 2017 | 4018 | 0.060 |
Why?
| | Delphi Technique | 2 | 2017 | 273 | 0.060 |
Why?
| | Pain | 2 | 2022 | 755 | 0.060 |
Why?
| | Autonomic Nerve Block | 1 | 2024 | 8 | 0.060 |
Why?
| | Celiac Plexus | 1 | 2024 | 6 | 0.060 |
Why?
| | Hospital Units | 1 | 2004 | 26 | 0.060 |
Why?
| | Health Care Surveys | 3 | 2014 | 563 | 0.060 |
Why?
| | Cohort Studies | 5 | 2020 | 5718 | 0.060 |
Why?
| | Hypoxia | 1 | 2011 | 1107 | 0.060 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2025 | 64 | 0.060 |
Why?
| | Cyst Fluid | 2 | 2018 | 25 | 0.050 |
Why?
| | Tertiary Care Centers | 2 | 2016 | 160 | 0.050 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 5749 | 0.050 |
Why?
| | Diphenhydramine | 1 | 2023 | 37 | 0.050 |
Why?
| | Midazolam | 1 | 2023 | 56 | 0.050 |
Why?
| | Efficiency, Organizational | 1 | 2004 | 138 | 0.050 |
Why?
| | Missouri | 2 | 2014 | 61 | 0.050 |
Why?
| | Observer Variation | 2 | 2014 | 345 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 682 | 0.050 |
Why?
| | Disposable Equipment | 2 | 2009 | 19 | 0.050 |
Why?
| | Electrocoagulation | 1 | 2023 | 40 | 0.050 |
Why?
| | Fentanyl | 1 | 2023 | 94 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 522 | 0.050 |
Why?
| | Animals | 3 | 2020 | 36768 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 244 | 0.050 |
Why?
| | Esophagitis, Peptic | 1 | 2002 | 15 | 0.050 |
Why?
| | Guidelines as Topic | 2 | 2015 | 276 | 0.050 |
Why?
| | Mass Screening | 1 | 2010 | 1262 | 0.050 |
Why?
| | Neoplasms | 1 | 2016 | 2644 | 0.050 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 199 | 0.050 |
Why?
| | Endoscopes | 2 | 1998 | 17 | 0.040 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2001 | 39 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 3 | 2006 | 2677 | 0.040 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2001 | 78 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2023 | 245 | 0.040 |
Why?
| | Hyperthermia, Induced | 1 | 2002 | 116 | 0.040 |
Why?
| | Silicones | 1 | 2020 | 25 | 0.040 |
Why?
| | Hemostatic Techniques | 1 | 2000 | 47 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1235 | 0.040 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2000 | 44 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 76 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 53 | 0.040 |
Why?
| | Contraindications | 2 | 2017 | 90 | 0.040 |
Why?
| | Technology Assessment, Biomedical | 5 | 1998 | 34 | 0.040 |
Why?
| | Feasibility Studies | 2 | 2018 | 947 | 0.040 |
Why?
| | Equivalence Trials as Topic | 1 | 2019 | 8 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 322 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 1043 | 0.040 |
Why?
| | General Surgery | 1 | 2000 | 169 | 0.040 |
Why?
| | Adenocarcinoma, Mucinous | 2 | 2009 | 80 | 0.040 |
Why?
| | Probability | 2 | 2009 | 309 | 0.040 |
Why?
| | Resuscitation | 1 | 2000 | 250 | 0.040 |
Why?
| | Electrosurgery | 1 | 1998 | 43 | 0.040 |
Why?
| | Electrodes | 1 | 1998 | 113 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1323 | 0.040 |
Why?
| | Swine | 1 | 2020 | 773 | 0.040 |
Why?
| | Radiology | 1 | 2000 | 181 | 0.040 |
Why?
| | Reference Standards | 1 | 2018 | 183 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 3 | 2014 | 1294 | 0.030 |
Why?
| | Surgical Instruments | 1 | 2018 | 52 | 0.030 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2018 | 95 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 430 | 0.030 |
Why?
| | Granulation Tissue | 1 | 2016 | 6 | 0.030 |
Why?
| | Manometry | 2 | 2001 | 95 | 0.030 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2008 | 181 | 0.030 |
Why?
| | Organizational Policy | 1 | 2017 | 82 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 991 | 0.030 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| | Patient Admission | 1 | 2018 | 191 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 4 | 0.030 |
Why?
| | Gastric Fistula | 1 | 1996 | 9 | 0.030 |
Why?
| | Tissue Banks | 1 | 2016 | 16 | 0.030 |
Why?
| | Cutaneous Fistula | 1 | 1996 | 14 | 0.030 |
Why?
| | Fasciitis, Necrotizing | 1 | 1996 | 15 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 17 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 98 | 0.030 |
Why?
| | Foreign-Body Migration | 1 | 1996 | 34 | 0.030 |
Why?
| | Digestive System | 1 | 1995 | 28 | 0.030 |
Why?
| | Prevalence | 2 | 2015 | 2712 | 0.030 |
Why?
| | Iopamidol | 1 | 1995 | 17 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 1995 | 5 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 1969 | 0.030 |
Why?
| | Image-Guided Biopsy | 1 | 2015 | 39 | 0.030 |
Why?
| | Decision Trees | 1 | 2015 | 94 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2015 | 2847 | 0.030 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 116 | 0.030 |
Why?
| | Peritonitis | 1 | 1996 | 84 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 112 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 170 | 0.030 |
Why?
| | Markov Chains | 1 | 2015 | 122 | 0.030 |
Why?
| | Netherlands | 1 | 2015 | 88 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 627 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11069 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 205 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2017 | 257 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 400 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1036 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 268 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3566 | 0.030 |
Why?
| | Incidental Findings | 1 | 2015 | 87 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2015 | 328 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2014 | 83 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 679 | 0.030 |
Why?
| | Lipids | 1 | 2018 | 665 | 0.030 |
Why?
| | Advisory Committees | 1 | 2015 | 219 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 1995 | 267 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1995 | 200 | 0.030 |
Why?
| | Patient Participation | 1 | 2017 | 416 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 545 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 171 | 0.030 |
Why?
| | Medicaid | 1 | 2017 | 433 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1281 | 0.030 |
Why?
| | Patient Selection | 1 | 2017 | 689 | 0.020 |
Why?
| | Program Evaluation | 1 | 2017 | 886 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 584 | 0.020 |
Why?
| | Sphincter of Oddi | 1 | 2012 | 5 | 0.020 |
Why?
| | Radio Waves | 2 | 2003 | 18 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2018 | 802 | 0.020 |
Why?
| | Colic | 1 | 1992 | 8 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 738 | 0.020 |
Why?
| | Esophagitis | 1 | 2013 | 67 | 0.020 |
Why?
| | Mediastinum | 1 | 2012 | 25 | 0.020 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2013 | 125 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 747 | 0.020 |
Why?
| | Palliative Care | 1 | 2019 | 743 | 0.020 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 47 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2015 | 418 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 205 | 0.020 |
Why?
| | Heartburn | 2 | 2001 | 12 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1772 | 0.020 |
Why?
| | Edema | 1 | 2011 | 129 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 14 | 0.020 |
Why?
| | Body Height | 1 | 1991 | 199 | 0.020 |
Why?
| | Preoperative Care | 1 | 1992 | 356 | 0.020 |
Why?
| | Gastroscopes | 1 | 2010 | 3 | 0.020 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 23 | 0.020 |
Why?
| | Epithelium | 1 | 2011 | 311 | 0.020 |
Why?
| | Duodenoscopy | 1 | 2009 | 7 | 0.020 |
Why?
| | Methods | 1 | 1989 | 65 | 0.020 |
Why?
| | Punctures | 1 | 1989 | 39 | 0.020 |
Why?
| | Radiography | 1 | 1992 | 829 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1273 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2001 | 564 | 0.020 |
Why?
| | Injections | 1 | 2010 | 181 | 0.020 |
Why?
| | Reference Values | 1 | 1991 | 817 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1991 | 548 | 0.020 |
Why?
| | Adenocarcinoma, Papillary | 1 | 2009 | 12 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2009 | 67 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 891 | 0.020 |
Why?
| | Light | 1 | 2011 | 382 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1991 | 265 | 0.020 |
Why?
| | Age Distribution | 1 | 2009 | 391 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 376 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 178 | 0.020 |
Why?
| | ras Proteins | 1 | 2009 | 151 | 0.020 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2008 | 135 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1991 | 424 | 0.020 |
Why?
| | Specimen Handling | 1 | 2009 | 178 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 267 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 3290 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2008 | 138 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 896 | 0.020 |
Why?
| | Safety Management | 1 | 2007 | 119 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2008 | 243 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 326 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1319 | 0.020 |
Why?
| | Thoracic Surgery | 1 | 2008 | 132 | 0.020 |
Why?
| | Exercise | 1 | 2017 | 2038 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1318 | 0.010 |
Why?
| | Cross-Sectional Studies | 2 | 2008 | 5417 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 646 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1731 | 0.010 |
Why?
| | Comorbidity | 1 | 2009 | 1611 | 0.010 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2004 | 94 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9442 | 0.010 |
Why?
| | Child | 2 | 2018 | 21968 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 2068 | 0.010 |
Why?
| | False Negative Reactions | 1 | 2002 | 53 | 0.010 |
Why?
| | Reoperation | 2 | 1996 | 565 | 0.010 |
Why?
| | Gastric Acidity Determination | 1 | 2002 | 7 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2009 | 1157 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 46 | 0.010 |
Why?
| | Cholangiocarcinoma | 1 | 2001 | 104 | 0.010 |
Why?
| | Computer Simulation | 1 | 2004 | 973 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 108 | 0.010 |
Why?
| | Safety | 1 | 1998 | 340 | 0.010 |
Why?
| | Radiology, Interventional | 1 | 1996 | 33 | 0.010 |
Why?
| | Oximetry | 1 | 1995 | 95 | 0.010 |
Why?
| | Blood Pressure Determination | 1 | 1995 | 156 | 0.010 |
Why?
| | Technetium Tc 99m Disofenin | 1 | 1992 | 3 | 0.010 |
Why?
| | Sincalide | 1 | 1992 | 5 | 0.010 |
Why?
| | Organotechnetium Compounds | 1 | 1992 | 10 | 0.010 |
Why?
| | Imino Acids | 1 | 1992 | 5 | 0.010 |
Why?
| | Gallbladder | 1 | 1992 | 19 | 0.010 |
Why?
| | Electrocardiography | 1 | 1995 | 628 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1992 | 118 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1992 | 102 | 0.010 |
Why?
| | Glycine | 1 | 1992 | 175 | 0.010 |
Why?
| | Chronic Disease | 1 | 1995 | 1784 | 0.000 |
Why?
| | Pregnancy | 1 | 2001 | 6731 | 0.000 |
Why?
|
|
Edmundowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|